Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are nine reported by Becker's Hospital Review since Oct. 28:
- LivaNova recalls device to treat seizures, depression
London medical device-maker LivaNova is recalling a system that treats adults and children over 4 years old with partial-onset seizures that haven't responded to epilepsy medications after discovering an error that causes the system to stop delivering therapy. - Lannett recalls contaminated seizure treatment
Lannett Company, a Philadelphia-based drugmaker, is recalling two lots of its seizure treatment after discovering bacterial contamination. - Glenmark recalls ranitidine products, ceases US distribution
Glenmark Pharmaceuticals, an India-based drugmaker, recalled all unexpired lots of its 150 mg and 300 mg ranitidine tablets Dec. 17 after finding the products may contain a human carcinogen. Glenmark also ceased distribution of its ranitidine products in the U.S. while it tests its products. - B. Braun Medical recalls blood administration sets due to potential for leakage
B. Braun Medical is recalling 43,026 blood administration sets after the company received complaints about the potential for leakage. - Precision Dose recalls ranitidine products
Precision Dose, a South Beloit, Ill.-based prescription drug supplier, is recalling five lots of its ranitidine oral solution after finding a potential human carcinogen. - American Health Packaging recalls ranitidine syrup
American Health Packaging is the latest company to recall a ranitidine product after discovering it produces a possible carcinogen. - Fagron recalls topical anesthetic due to contamination concerns
Fagron is recalling all unexpired lots of its topical anesthesia that was distributed nationwide to hospitals, pharmacies and distributors after the FDA found possible bacterial contamination. - ICU Medical recalls 2 IV fluids
ICU Medical is recalling two intravenous fluids that were sent to hospitals nationwide after particulate matter was discovered in the injections. - Mylan recalls anxiety drug
Mylan is recalling one lot of its generic version of Xanax, called alprazolam tablets, due to the potential presence of a foreign substance.
More articles on pharmacy:
Drugmakers shift from clinical trials, mine EMRs for drug approvals
Momenta settles drug monopoly lawsuit with Nashville hospital for $35M
Merck scores 1st U.S.-approved Ebola vaccine
LivaNova recalls device to treat seizures, depression
London medical device-maker LivaNova is recalling a system that treats adults and children over 4 years old with partial-onset seizures that haven't responded to epilepsy medications after discovering an error that causes the system to stop delivering therapy.
Lannett recalls contaminated seizure treatment
Lannett Company, a Philadelphia-based drugmaker, is recalling two lots of its seizure treatment after discovering bacterial contamination.
Glenmark recalls ranitidine products, ceases US distribution
Glenmark Pharmaceuticals, an India-based drugmaker, recalled all unexpired lots of its 150 mg and 300 mg ranitidine tablets Dec. 17 after finding the products may contain a human carcinogen. Glenmark also ceased distribution of its ranitidine products in the U.S. while it test its products.
B. Braun Medical recalls blood administration sets due to potential for leakage
B. Braun Medical is recalling 43,026 blood administration sets after the company received complaints about the potential for leakage.
Precision Dose recalls ranitidine products
Precision Dose, a South Beloit, Ill.-based prescription drug supplier, is recalling five lots of its ranitidine oral solution after finding a potential human carcinogen.
American Health Packaging recalls ranitidine syrup
American Health Packaging is the latest company to recall a ranitidine product after discovering it produces a possible carcinogen.
Fagron recalls topical anesthetic due to contamination concerns
Fagron is recalling all unexpired lots of its topical anesthesia that was distributed nationwide to hospitals, pharmacies and distributors after the FDA found possible bacterial contamination.
ICU Medical recalls 2 IV fluids
ICU Medical is recalling two intravenous fluids that were sent to hospitals nationwide after particulate matter was discovered in the injections.
Mylan recalls anxiety drug
Mylan is recalling one lot of its generic version of Xanax, called alprazolam tablets, due to the potential presence of a foreign substance.